Proactive Diagnostics
Proactive Diagnostics (aka PLC Diagnostics) is developing a novel diagnostic product for routine monitoring of Heart Failure (HF) patients.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Thousand Oaks, CA, US
- Currency USD
- Founded March 2016
- Employees 3
- Incorporation Type C-corp
- Website plcds.com
Company Summary
Proactive Diagnostics is developing a novel diagnostic product* for routine monitoring of Heart Failure (HF) patients at the Point of Care. This much needed solution will enable care-givers, Cardiologists and Primary Care Physicians (PCP’s), to better manage the care of HF patients based on data, improve their patients’ quality of life, and significantly reduce cost to the system.
* Exclusive license from our sister company, PLC Diagnostics.
Team
-
Founder, President & CSOPreviously founder president and CSO of PLC Diagnostics and inventor of the Q-SENS bio-sensing technology. Building on 20 years of experience in the design and realization of Planar-Lightwave-Circuits (PLC) on silicon wafers, Dr. Duer is a visionary who engaged in building a next generation bio-sensing platform bridging between the semiconductor fab industry and Point-of-Care medical diagnostics.
-
Brian Noland - Ph.D.Founder & VPSr. Director, New Technologies & Reagents Business at Alere (Biosite) until 2014, involved in several product development projects that led to both regulatory submissions and new product launches. Brian's expertise covers a broad range of activities germane to diagnostics including: early R&D, assay development, reagent design/development, design controls, transfer to manufacturing, V&V, regulatory submissions, and optical instrumentation.
Advisors
-
Prof. Mark A. MungerUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.